CPC A61M 5/20 (2013.01) [A61M 5/14244 (2013.01); A61M 5/14248 (2013.01); A61M 5/158 (2013.01); A61M 5/24 (2013.01); A61M 5/31501 (2013.01); A61M 5/31568 (2013.01); A61M 5/3202 (2013.01); A61M 5/3243 (2013.01); A61M 5/3257 (2013.01); A61M 5/326 (2013.01); A61M 5/5086 (2013.01); G06Q 50/01 (2013.01); G06Q 50/22 (2013.01); G16H 20/17 (2018.01); G16H 40/00 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); A61M 2005/3267 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3576 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2205/581 (2013.01); A61M 2205/6009 (2013.01)] | 21 Claims |
1. A drug delivery device comprising:
a reservoir;
a delivery member having a proximal end connected or configured to be connected in fluid communication with the reservoir and a distal end configured for insertion into a patient;
a housing having an opening, the distal end of the delivery member being configured to extend through the opening in an operative state;
an adhesive for removably coupling the housing to skin of the patient;
a removable cover covering at least a portion of the adhesive;
a controllable element;
a patient contact sensor; and
the drug delivery device being programmed or configured to:
(a) determine if the at least a portion of the adhesive has been exposed,
(b) determine if the drug delivery device is in contact with the patient, and
(c) subsequent to or simultaneously with (b), output a control signal to the controllable element.
|